AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Physical Inactivity and Appetite Regulation

RecruitingNAAges 40 Years - 55 YearsMaleCopenhagen University Hospital, Rigshospitalet
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The goal of this parallel-group, two-arm, assessor-blinded, randomised clinical trial is to investigate the effects of reducing physical activity on food intake and satiety in physically active and healthy males, 40-55 years of age. The main questions it aims to answer are: * Does physical inactivity affect GLP-1 stimulated food intake? * Does physical inactivity affect food preferences, satiety and other mechanisms supporting appetite regulation? Participants will be randomised (1:1) to two weeks of either no intervention (control group) or inactivity. Inactivity will be implemented as cessation of active commuting and all other structured exercise. Furthermore, steps will be reduced to a maximum of 1500 steps/day. Researchers will compare the inactivity group to the control group to see if physical inactivity impairs appetite regulation.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Male 2. Age โ‰ฅ 40 years and โ‰ค 55 years 3. Body mass index (BMI) \> 20 and \< 25 kg/m2 4. Physical activity level should as a minimum include: Active commuting by biking a minimum of 10 km, four days per week or an equivalent amount of other physical activity four days per week. 5. Healthy (based on self-reporting, pre-study medical examination and biochemical screening) 6. Can adhere to two weeks of inactivity (refrain from running, cycling and all other exercise while reducing steps to max. 1500 pr. day) 7. Caucasian 8. No change in body weight \> 5 kg within the last 6 months 9. Eats breakfast and lunch daily 10. Does not follow specific dietary restrictions 11. No disliking of spaghetti bolognese 12. No diagnosis of psychiatric disorder or treatment with anti-depressant or anti-psychotic medication 13. No history of suicidal behavior or ideations. 14. No previous surgical treatment for obesity 15. No cardiovascular disease 16. No rheumatologic disease 17. No metabolic/endocrine disease 18. No liver disease (ASAT or ALAT \>2x upper normal range) 19. No other chronic disease 20. No elite sports 21. No frequent or chronic use of medications affecting bodyweight, physical performance, or inflammation (NSAIDS, DMARDS, corticosteroids) 22. No current infection 23. No history of cancer 24. No anemia (hematocrit \<33%) 25. No smoking 26. No participation in other research intervention studies Exclusion Criteria: 1. Clinical or biochemical signs of disease 2. HbA1c \> 39 mmol/mol 3. Unable to allocate the needed time to fulfill the intervention 4. Language barrier, mental incapacity, unwillingness, or inability to understand and be able to complete the interventions
๐Ÿ’Š

What it tests

  • Inactivity
๐Ÿ“

Where

1 site
Copenhagen University Hospital
Copenhagen, Denmark
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy